You are here

  • Home
  • Archive
  • Volume 106, Issue 10
  • Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study

Article metrics

Article menu
Clinical science
Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study

 

Online download statistics by month:

Online download statistics by month: May 2021 to April 2023

AbstractFullPdf
May 202112451207770
Jun 2021182718171506
Jul 202110541053752
Aug 202122421463
Sep 202115214335
Oct 202115114652
Nov 202116616266
Dec 202116315939
Jan 202211511129
Feb 202215515222
Mar 202218518539
Apr 202221521142
May 202220620027
Jun 202225525933
Jul 202219519032
Aug 202219519521
Sep 2022877889124
Oct 2022612609127
Nov 202239939870
Dec 202238939452
Jan 202330630053
Feb 202326226348
Mar 202330630454
Apr 202318017246
Total983497334102